Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists

Clinical trial NCT04183192 · COMPLETED

Trial details

NCT number: NCT04183192
Sponsor: Food and Drug Administration (FDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics Pharmacodynamics

Start date: 2020-02-17
Primary completion: 2021-04-04
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.